The Boston Children's Hospital Neonatal and Congenital Anomaly Neurosurgery Program was created to diagnose and treat neurologic anomalies as early as possible so that these patients have the greatest chance of experiencing optimal development and leading healthy full, healthy lives.
The Neonatal and Congenital Anomaly Neurosurgery Program at Children’s Hospital Boston evaluates, diagnoses and treats newborns with neurologic congenital anomalies. A congenital anomaly is sometimes identified during the mother’s pregnancy or soon after the birth of the baby.
Some neurologic congenital anomalies include:
Our program includes an experienced multidisciplinary team of clinicians, all with specialized training in the care of children with neurologic congenital anomalies. Our team members represent multiple departments, programs and services across Children's, including:
About our director: Benjamin Warf, MD
Dr. Warf received his medical degree from Harvard University. He began his career in pediatric neurosurgery at Boston Children's Hospital in 1991 as the first Pediatric Fellow in Neurological Surgery. From Children’s, he took a position at University of Kentucky where he became Chief of Pediatric Neurosurgery.
In 2000, Dr. Warf and his family moved to Uganda to help found a hospital for pediatric neurosurgery with CURE International, a non-profit Christian medical mission organization. While at CURE, he served as Medical Director and established the only pediatric neurosurgery hospital in Sub-Saharan Africa.
Dr. Warf was the first to identify neonatal infection as the chief cause of pediatric hydrocephalus in a developing country, and remains involved in working to uncover its pathogenesis in order to ultimately construct prevention strategies. He developed a novel surgical technique for treating hydrocephalus in infants, combining endoscopic third ventriculostomy with bilateral choroid plexus cauterization (ETV/CPC).
Since returning to the United States, DrWarf has investigated the role of ETV/CPC in North American infants, and also continues to work in international neurosurgery development. From 2006 to 2009, Dr. Warf was neurosurgeon at Dupont Hospital for Children in Wilmington, Delaware. He rejoined the team at Children’s Boston in 2009.
Read more about Dr. Warf:
Innovative treatment for infants with hydrocephalus: ETV/CPC
Boston Children's Neonatal and Congenital Anomaly Neurosurgery Program Director Benjamin Warf, MD, developed a novel surgical technique for treating hydrocephalus in infants, combining endoscopic third ventriculostomy with bilateral choroid plexus cauterization (ETV/CPC).
ETV/CPC involves the use of an endoscope to create an opening in the floor of the third ventricle and combined with endoscopic cauterization of the choroid plexus (CP) at the time of the ETV.
Cauterization of the CP tissue in the lateral ventricles of the brain has been demonstrated to decrease cerebrospinal fluid (CSF) production. This combined procedure addresses both production and absorption issues to return the flow of CSF in the brain to a normal state. The combined procedure is shown to be a more effective treatment in infants then ETV alone.
Learn more about ETV/CPC.